Unique ID issued by UMIN | UMIN000050349 |
---|---|
Receipt number | R000057334 |
Scientific Title | Impact of comorbidities on Migraine quality of life:Cross-sectional study using receipt data and questionnaire survey |
Date of disclosure of the study information | 2023/03/01 |
Last modified on | 2023/09/04 05:42:34 |
Impact of comorbidities on Migraine quality of life:Cross-sectional study using receipt data and questionnaire survey
Impact of comorbidities on Migraine quality of life
Impact of comorbidities on Migraine quality of life:Cross-sectional study using receipt data and questionnaire survey
Impact of comorbidities on Migraine quality of life:Cross-sectional study using receipt data and questionnaire survey
Japan |
Migraine
Neurology |
Others
NO
To investigate the relationship between QOL associated with migraines and comorbidities
Others
To investigate the relationship between WPAI associated with migraines and comorbidities
MS-QOL(Migraine-Specific Quality of Life)
WPAI(Work Productivity and Activity Impairment)
Observational
19 | years-old | <= |
75 | years-old | > |
Male and Female
Health insurance union members (approximately 600,000) who have agreed to secondary use of medical data contracted by DeSC, who are 19 to 75 years old, and who are health promotion support service app kencom provided by DeSC for health insurance unions 150,000 registrants (about 150,000) were assessed as having migraine (including suspected migraine) based on the ICHD-3 questionnaire. group
none
691
1st name | hiromi |
Middle name | |
Last name | sano |
Otsuka Pharmaceuticals Co., Ltd
Medical Affairs Department
540-0021
3-2-27 Ote-dori,Chuo-ku,Osaka 540-0021
06-6943-7722
sanoh@otsuka.jp
1st name | hiromi |
Middle name | |
Last name | sano |
Otsuka Pharmaceuticals Co., Ltd
Medical Affairs Department
540-0021
3-2-27 Ote-dori,Chuo-ku,Osaka 540-0021
06-6943-7722
sanoh@otsuka.jp
Otsuka Pharmaceutical Co., Ltd.
self-procurement
Profit organization
The research ethics committee of Otsuka Pharmaceutical Co., Ltd
463-10 Kagasuno,Kawauchi-cho,Tokushima-city,Tokushima
0886652126
Suzuki.Takashi@otsuka.jp
NO
2023 | Year | 03 | Month | 01 | Day |
Unpublished
674
The results suggest that the factors influencing MS-QOL were cerebrovascular depression for RR and RP, schizophrenia and sleep disorders for EF. The number of comorbidities did not influence MS-QOL by the number of comorbidities.
Factors influencing WPAI were sleep disorders in presenteeism and overall work impairment, and depression in activity impairment. The number of comorbidities did not influence the WPAI in terms of the number of comorbidities.
2023 | Year | 09 | Month | 04 | Day |
Completed
2022 | Year | 06 | Month | 28 | Day |
2022 | Year | 06 | Month | 29 | Day |
2022 | Year | 12 | Month | 06 | Day |
2023 | Year | 02 | Month | 28 | Day |
2023 | Year | 04 | Month | 21 | Day |
To investigate the relationship between QOL associated with migraines and comorbidities
2023 | Year | 02 | Month | 15 | Day |
2023 | Year | 09 | Month | 04 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000057334